|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.56 USD | +1.84% |
|
+0.87% | +22.06% |
| 08-07 | Incyte Insider Sold Shares Worth $273,646, According to a Recent SEC Filing | MT |
| 08-07 | Incyte Insider Sold Shares Worth $1,305,422, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 24.44B | |||||
| 78.32B | |||||
| 51.1B | |||||
| 49.18B | |||||
| 44.71B | - | ||||
| 30.72B |
- Stock Market
- Stocks
- INCY Stock
- Charts Incyte Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
